vs

Side-by-side financial comparison of Information Services Group Inc. (III) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $61.2M, roughly 1.4× Information Services Group Inc.). Information Services Group Inc. runs the higher net margin — 4.3% vs -38.1%, a 42.3% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 5.9%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -2.4%).

EBSCO Information Services, headquartered in Ipswich, Massachusetts, is a division of EBSCO Industries Inc., a private company headquartered in Birmingham, Alabama. EBSCO provides products and services to libraries of many types around the world. Its products include EBSCONET, a complete e-resource management system, and EBSCOhost, which supplies a fee-based online research service with 375 full-text databases, a collection of 600,000-plus ebooks, subject indexes, point-of-care medical refere...

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

III vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.4× larger
PRCT
$83.1M
$61.2M
III
Growing faster (revenue YoY)
PRCT
PRCT
+14.3% gap
PRCT
20.2%
5.9%
III
Higher net margin
III
III
42.3% more per $
III
4.3%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
-2.4%
III

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
III
III
PRCT
PRCT
Revenue
$61.2M
$83.1M
Net Profit
$2.6M
$-31.6M
Gross Margin
44.8%
64.9%
Operating Margin
8.4%
-4.1%
Net Margin
4.3%
-38.1%
Revenue YoY
5.9%
20.2%
Net Profit YoY
-14.1%
-27.9%
EPS (diluted)
$0.06
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
III
III
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$61.2M
$76.4M
Q3 25
$62.4M
$83.3M
Q2 25
$61.6M
$79.2M
Q1 25
$59.6M
$69.2M
Q4 24
$57.8M
$68.2M
Q3 24
$61.3M
$58.4M
Q2 24
$64.3M
$53.4M
Net Profit
III
III
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$2.6M
$-29.8M
Q3 25
$3.1M
$-21.4M
Q2 25
$2.2M
$-19.6M
Q1 25
$1.5M
$-24.7M
Q4 24
$3.0M
$-18.9M
Q3 24
$1.1M
$-21.0M
Q2 24
$2.0M
$-25.6M
Gross Margin
III
III
PRCT
PRCT
Q1 26
64.9%
Q4 25
44.8%
60.6%
Q3 25
42.2%
64.8%
Q2 25
42.2%
65.4%
Q1 25
43.1%
63.9%
Q4 24
41.5%
64.0%
Q3 24
40.4%
63.2%
Q2 24
39.5%
59.0%
Operating Margin
III
III
PRCT
PRCT
Q1 26
-4.1%
Q4 25
8.4%
-40.6%
Q3 25
7.4%
-27.8%
Q2 25
7.6%
-28.0%
Q1 25
5.7%
-39.7%
Q4 24
0.3%
-28.9%
Q3 24
7.0%
-38.4%
Q2 24
5.7%
-50.3%
Net Margin
III
III
PRCT
PRCT
Q1 26
-38.1%
Q4 25
4.3%
-39.1%
Q3 25
4.9%
-25.7%
Q2 25
3.5%
-24.7%
Q1 25
2.5%
-35.8%
Q4 24
5.3%
-27.6%
Q3 24
1.9%
-35.9%
Q2 24
3.2%
-48.0%
EPS (diluted)
III
III
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$0.06
$-0.54
Q3 25
$0.06
$-0.38
Q2 25
$0.04
$-0.35
Q1 25
$0.03
$-0.45
Q4 24
$0.07
$-0.34
Q3 24
$0.02
$-0.40
Q2 24
$0.04
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
III
III
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$28.7M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$94.7M
$347.7M
Total Assets
$211.0M
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
III
III
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$28.7M
$286.5M
Q3 25
$28.7M
$294.3M
Q2 25
$25.2M
$302.7M
Q1 25
$20.1M
$316.2M
Q4 24
$23.1M
$333.7M
Q3 24
$9.7M
$196.8M
Q2 24
$11.8M
$214.1M
Total Debt
III
III
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
III
III
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$94.7M
$365.9M
Q3 25
$94.7M
$380.3M
Q2 25
$94.1M
$385.8M
Q1 25
$95.0M
$389.2M
Q4 24
$96.3M
$402.2M
Q3 24
$96.6M
$241.2M
Q2 24
$95.5M
$251.8M
Total Assets
III
III
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$211.0M
$508.1M
Q3 25
$213.3M
$511.5M
Q2 25
$200.7M
$513.1M
Q1 25
$202.4M
$519.4M
Q4 24
$204.5M
$534.0M
Q3 24
$227.1M
$374.1M
Q2 24
$235.3M
$374.4M
Debt / Equity
III
III
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
III
III
PRCT
PRCT
Operating Cash FlowLast quarter
$5.1M
Free Cash FlowOCF − Capex
$4.3M
FCF MarginFCF / Revenue
7.0%
Capex IntensityCapex / Revenue
1.2%
Cash ConversionOCF / Net Profit
1.94×
TTM Free Cash FlowTrailing 4 quarters
$25.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
III
III
PRCT
PRCT
Q1 26
Q4 25
$5.1M
$-10.3M
Q3 25
$11.1M
$-6.6M
Q2 25
$11.9M
$-15.0M
Q1 25
$978.0K
$-17.0M
Q4 24
$6.6M
$-32.4M
Q3 24
$8.8M
$-18.8M
Q2 24
$2.2M
$-15.7M
Free Cash Flow
III
III
PRCT
PRCT
Q1 26
Q4 25
$4.3M
$-12.2M
Q3 25
$9.5M
$-9.5M
Q2 25
$11.1M
$-17.8M
Q1 25
$141.0K
$-18.8M
Q4 24
$6.0M
$-33.6M
Q3 24
$8.4M
$-19.0M
Q2 24
$1.3M
$-16.8M
FCF Margin
III
III
PRCT
PRCT
Q1 26
Q4 25
7.0%
-15.9%
Q3 25
15.2%
-11.4%
Q2 25
18.0%
-22.5%
Q1 25
0.2%
-27.2%
Q4 24
10.4%
-49.2%
Q3 24
13.7%
-32.6%
Q2 24
2.0%
-31.4%
Capex Intensity
III
III
PRCT
PRCT
Q1 26
Q4 25
1.2%
2.4%
Q3 25
2.5%
3.4%
Q2 25
1.4%
3.5%
Q1 25
1.4%
2.7%
Q4 24
0.9%
1.7%
Q3 24
0.6%
0.4%
Q2 24
1.4%
2.0%
Cash Conversion
III
III
PRCT
PRCT
Q1 26
Q4 25
1.94×
Q3 25
3.62×
Q2 25
5.46×
Q1 25
0.66×
Q4 24
2.15×
Q3 24
7.66×
Q2 24
1.07×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

III
III

Segment breakdown not available.

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons